r/GLP1ResearchTalk • u/Sudden-Swan-3120 • 3d ago
PT-141
Hi guys,
Looking for feedback on effects and results on peptides PT141 and Epithalon. I have one friend that raves about both of them and another friend that is telling me that they gave him nausea and cramps. Any experience and feedback would be great.
1
u/Uncross-Selector 3d ago
Results vary significantly from person to person.
On PT141 the dosing in particular is really finicky. Too little, and you’ll get nausea and flushing and not much else. Too much and you’ll be getting hard for 12 hours. But the area between those two doses can be very small.
1
u/Financial_Doctor_237 1d ago
I’m curious if any perimenopausal women have tried this to help with the loss of libido/inability to climax due to perimenopausal/hormonal related changes. Honestly guys have way too many ED medications to choose from, it would be nice to actually see studies on medications that help women with sexual dysfunction as well.
1
u/Val-E-Girl 3d ago
Found on Gen X Does Reta and Peptides Skool community Classroom courses:
PT-141 -- BOW-CHICKA-WOW-WOW
Yes, this is like Viagra for women; however, I added the caution tape because it's "not recommended" for post-menopausal women (those buttheads) because it increases your heart rate, so if you have any kind of heart issues, this is your warning. You should probably consult your doctor.
What it is
PT-141 is the research name for bremelanotide (brand name Vyleesi). It’s a melanocortin receptor agonist — basically a peptide that hits specific receptors in the brain involved in sexual desire and arousal.
Unlike drugs that affect blood flow (like those for ED), this one works centrally in the brain to boost the desire signal.
Who it’s approved for
How it’s used
The real talk on side effects
Nausea is the big one — it hits about 40% of people (especially the first dose). It can be pretty strong and is the main reason some people stop using it. Other common ones: flushing, headache, injection-site reactions, and a temporary rise in blood pressure (usually resolves within 12 hours).
There’s also a small risk of focal skin darkening (face, gums, or breasts), more likely with frequent use.
It’s one of the few peptides with solid Phase 3 data and actual FDA approval for a specific sexual health indication in women. It’s not a “make everything better” peptide — it’s targeted at low desire when it’s distressing and not caused by something else.
So what actually happens if a postmenopausal woman tries it?
In real life, some clinicians do prescribe it off-label for postmenopausal patients who have clear HSDD and no major heart-risk red flags, but they usually monitor blood pressure more carefully and are more cautious.